Shoichi Iriguchi

1.4k total citations
17 papers, 625 citations indexed

About

Shoichi Iriguchi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Shoichi Iriguchi has authored 17 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Shoichi Iriguchi's work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (10 papers) and CRISPR and Genetic Engineering (5 papers). Shoichi Iriguchi is often cited by papers focused on CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (10 papers) and CRISPR and Genetic Engineering (5 papers). Shoichi Iriguchi collaborates with scholars based in Japan, United States and China. Shoichi Iriguchi's co-authors include Shin Kaneko, Tatsuki Ueda, Yasushi Uemura, Atsutaka Minagawa, Yutaka Yasui, Yohei Kawai, Tetsuya Nakatsura, Norihiro Ueda, Y. Miyake and Bo Wang and has published in prestigious journals such as Nature Communications, Blood and Cell stem cell.

In The Last Decade

Shoichi Iriguchi

17 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichi Iriguchi Japan 12 463 330 259 102 94 17 625
Tamara Laskowski United States 7 395 0.9× 201 0.6× 403 1.6× 90 0.9× 76 0.8× 8 645
Kirsten L. Todd Australia 5 585 1.3× 230 0.7× 475 1.8× 118 1.2× 97 1.0× 5 800
Atsutaka Minagawa Japan 6 265 0.6× 363 1.1× 133 0.5× 89 0.9× 68 0.7× 7 534
Simona Porcellini Italy 14 229 0.5× 282 0.9× 235 0.9× 55 0.5× 153 1.6× 25 581
Emma V. Petley Australia 5 624 1.3× 237 0.7× 511 2.0× 121 1.2× 101 1.1× 7 854
Martina Schüßler‐Lenz Germany 6 349 0.8× 180 0.5× 127 0.5× 103 1.0× 119 1.3× 9 445
Stina L. Wickström Sweden 14 344 0.7× 145 0.4× 367 1.4× 78 0.8× 49 0.5× 20 575
Pilvi Maliniemi Finland 10 272 0.6× 248 0.8× 138 0.5× 62 0.6× 92 1.0× 16 505
Alexander Biederstädt Germany 5 375 0.8× 155 0.5× 402 1.6× 81 0.8× 45 0.5× 9 604
Bindu George United States 7 417 0.9× 156 0.5× 136 0.5× 151 1.5× 102 1.1× 22 544

Countries citing papers authored by Shoichi Iriguchi

Since Specialization
Citations

This map shows the geographic impact of Shoichi Iriguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Iriguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Iriguchi more than expected).

Fields of papers citing papers by Shoichi Iriguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Iriguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Iriguchi. The network helps show where Shoichi Iriguchi may publish in the future.

Co-authorship network of co-authors of Shoichi Iriguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichi Iriguchi. A scholar is included among the top collaborators of Shoichi Iriguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichi Iriguchi. Shoichi Iriguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yano, Hisashi, Keiko Koga, Takayuki Sato, et al.. (2024). Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model. Cell stem cell. 31(6). 795–802.e6. 19 indexed citations
2.
Iriguchi, Shoichi, Tokuyuki Shinohara, Yoshiaki Kassai, et al.. (2023). Lineage tracing of T cell differentiation from T-iPSC by 2D feeder-free culture and 3D organoid culture. Frontiers in Immunology. 14. 1303713–1303713. 1 indexed citations
3.
Ueda, Tatsuki, Shoichi Iriguchi, Seitaro Terakura, et al.. (2022). Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Nature Biomedical Engineering. 7(1). 24–37. 48 indexed citations
4.
Yano, Hisashi, Takayuki Sato, Tokuyuki Shinohara, et al.. (2022). iPSC-Derived HLA-A2 CAR Tregs Showed Suppression of GvHD in a Xenograft Model. Blood. 140(Supplement 1). 2365–2366. 1 indexed citations
5.
Iriguchi, Shoichi, Yutaka Yasui, Yohei Kawai, et al.. (2021). A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. Nature Communications. 12(1). 430–430. 149 indexed citations
6.
Iwamoto, Yoshihiro, Masahiro Tanaka, Shoichi Iriguchi, et al.. (2021). Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease. Molecular Therapy — Methods & Clinical Development. 21. 262–273. 5 indexed citations
7.
Itoh, Takeshi, Yohei Kawai, Yutaka Yasui, et al.. (2021). The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells. Communications Biology. 4(1). 694–694. 20 indexed citations
8.
Wang, Bo, Shoichi Iriguchi, Masazumi Waseda, et al.. (2021). Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nature Biomedical Engineering. 5(5). 429–440. 118 indexed citations
10.
Iriguchi, Shoichi & Shin Kaneko. (2019). In Vitro Differentiation of T Cells: From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Methods in molecular biology. 2048. 59–70. 1 indexed citations
11.
Yano, Hisashi, Tokuyuki Shinohara, Keiko Koga, et al.. (2019). Guided Polarization of iPSC-Derived CD4SP Helper T Cells By CRISPR/Cas9-Based Genome-Editing. Blood. 134(Supplement_1). 1937–1937. 7 indexed citations
12.
Iriguchi, Shoichi & Shin Kaneko. (2018). Toward the development of true “off‐the‐shelf” synthetic T‐cell immunotherapy. Cancer Science. 110(1). 16–22. 25 indexed citations
13.
Ueda, Norihiro, Yasushi Uemura, Rong Zhang, et al.. (2018). Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell Response. Stem Cell Reports. 10(6). 1935–1946. 20 indexed citations
14.
Kawana‐Tachikawa, Ai, Shoichi Iriguchi, A Kumagai, et al.. (2018). Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA. Molecular Therapy — Nucleic Acids. 12. 793–804. 14 indexed citations
15.
Zhang, Rong, Tianyi Liu, Norihiro Ueda, et al.. (2016). Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells. Stem Cell Reports. 6(2). 213–227. 64 indexed citations
16.
Karagiannis, Peter, Shoichi Iriguchi, & Shin Kaneko. (2015). Reprogramming away from the exhausted T cell state. Seminars in Immunology. 28(1). 35–44. 24 indexed citations
17.
Iriguchi, Shoichi, Norihiro Kikuchi, Shin Kaneko, et al.. (2014). T-cell–restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung. Blood. 125(2). 370–382. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026